{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-N-4162", "FDA", "Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments - Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) manufactured by Moderna TX Inc.", "Nonrulemaking", "2026-05-28T20:40:49Z", "0b000064b9285dce", null, "OPEN", null, null, "[\"CBER\", \"2026-225\", \"Notice\", \"Vaccines and Related Biological Products\", \"Advisory Committee\", \"Request for Comments\", \"Safety and Effectiveness of MFLUSIVA\", \"(Influenza Vaccine, mRNA)\", \"manufactured by Moderna TX Inc.\", \"OPEN\"]", "CBER", "Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments - Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA)", null, null, "{\"displayProperties\": [{\"name\": \"abstract\", \"label\": \"General Information\", \"tooltip\": \"Describes an agency's specific regulatory action; equivalents: Abstract, Description, Docket Subject, Related To, Summary.\"}, {\"name\": \"generic\", \"label\": \"Docket Item Code\", \"tooltip\": \"An agency specific code that identifies the type of document that established the docket (regulatory action).\"}, {\"name\": \"program\", \"label\": \"Center\", \"tooltip\": \"The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code,  Location.\"}, {\"name\": \"field2\", \"label\": \"Docket Status\", \"tooltip\": \"Used to Identity that a Docket's Status is Open or Closed\"}, {\"name\": \"shortTitle\", \"label\": \"Short Title\", \"tooltip\": \"A combination of letters and or numbers assigned to an agency's regulatory action for purposes of brevity.\"}], \"keywords\": [\"CBER\", \"2026-225\", \"Notice\", \"Vaccines and Related Biological Products\", \"Advisory Committee\", \"Request for Comments\", \"Safety and Effectiveness of MFLUSIVA\", \"(Influenza Vaccine, mRNA)\", \"manufactured by Moderna TX Inc.\", \"OPEN\"], \"modifyDate\": \"2026-05-28T20:40:49Z\", \"dkAbstract\": \"OPEN\", \"agencyId\": \"FDA\", \"program\": \"CBER\", \"shortTitle\": \"Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments - Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA)\", \"subType2\": null, \"title\": \"Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments - Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) manufactured by Moderna TX Inc.\", \"generic\": \"N\", \"field1\": null, \"docketType\": \"Nonrulemaking\", \"petitionNbr\": null, \"rin\": null, \"organization\": null, \"legacyId\": null, \"subType\": null, \"category\": null, \"field2\": \"OPEN\", \"effectiveDate\": null, \"objectId\": \"0b000064b9285dce\"}", "single_get"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id", "rin", "dkabstract", "category", "subtype", "keywords", "program", "short_title", "effective_date", "organization", "attrs_raw", "attr_source"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-N-4162"], "units": {}, "query_ms": 0.2702309866435826, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}